Distribution and temporal regulation of the immune response in the rat brain to intracerebroventricular injection of interferon-gamma.
The response to intracerebroventricular administration of interferon (IFN)-gamma was examined in the adult Wistar rat brain: major histocompatibility complex (MHC) antigens class I and II, CD8 and CD4 antigens, and the macrophage/microglia antigen OX42 were analyzed in respect to saline-injected cases over 1 week. The glial cell type expressing MHC antigens was characterized with double labeling. IFN-gamma was thus found to induce MHC class I and II expression in microglia, identified by tomato lectin histochemistry, and not in GFAP-immunostained astrocytes. MHC antigen-expressing microglia was detected in the periventricular parenchyma, several fields of the cerebral cortex, cerebellum, major fiber tracts, and brainstem superficial parenchyma. Different gradients of density and staining intensity of the MHC-immunopositive elements were observed in these regions, in which MHC class I antigens persisted up to 1 week, when MHC class II induction had declined. Quantitative analysis pointed out the proliferation of OX42-immunoreactive cells in periventricular and basal brain regions. CD8+ T cells were observed in periventricular regions, basal forebrain, and fiber tracts 3 days after IFN-gamma injection and their density markedly increased by 7 days. CD4+ T cells were also seen and they were fewer than CD8+ ones. However, numerous CD4+ microglial cells were observed in periventricular and subpial regions, especially 1 week after IFN-gamma injection. Our data indicate that this proinflammatory cytokine mediates in vivo microglia activation and T cell infiltration in the brain and that the cells involved in this immune response display a regional selectivity and a different temporal regulation of antigen expression.
Peng
Z C
ZC
Institute of Anatomy and Histology, Medical Faculty, University of Verona, Italy.
Kristensson
K
K
Bentivoglio
M
M
D000818:Animals; D000911:Antibodies, Monoclonal; D001253:Astrocytes / Q000737:chemistry; D001921:Brain / Q000166:cytology / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000737:chemistry / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000737:chemistry / Q000276:immunology; D002552:Cerebral Ventricles / Q000276:immunology; D005455:Fluorescent Antibody Technique; D015395:Histocompatibility Antigens Class I / Q000032:analysis / Q000276:immunology; D007276:Injections, Intraventricular; D007371:Interferon-gamma / Q000494:pharmacology*; D016177:Macrophage-1 Antigen / Q000032:analysis / Q000276:immunology; D008285:Major Histocompatibility Complex / Q000276:immunology; D008297:Male; D017628:Microglia / Q000737:chemistry / Q000276:immunology; D009412:Nerve Fibers / Q000276:immunology; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000276:immunology*; D051381:Rats; D017208:Rats, Wistar
D000911:Antibodies, Monoclonal; D015395:Histocompatibility Antigens Class I; D016177:Macrophage-1 Antigen; D007371:Interferon-gamma